|
US2020330388A1
|
|
Dosage form comprising structural framework of two-dimensional elements
|
|
WO2020061383A1
|
|
Dosage form comprising structured solid-solution framework of sparingly-soluble drug and method for manufacture thereof
|
|
WO2019165106A2
|
|
Expanding structured dosage form
|
|
US2019344485A1
|
|
Method and apparatus for the manufacture of cellular solids
|
|
US2018271797A1
|
|
Method and apparatus for the manufacture of fibrous dosage forms
|
|
US2018303943A1
|
|
Dosage form comprising two-dimensional structural elements
|
|
WO2018013617A2
|
|
Method and apparatus for the manufacture of cellular solids
|
|
US2018049993A1
|
|
Fibrous dosage form
|
|
EP3368010A1
|
|
Solid dosage form immediate drug release and apparatus and method for manufacture thereof
|
|
US2016184230A1
|
|
Melt-processed polymeric cellular dosage form
|
